Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Curious about which travel cards have no annual fees? Find the best options to maximize your travel rewards.
26,862 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
A long-time investor explains why AbbVie’s mix of rapidly growing immunology drugs and a dependable dividend keeps dr...
Marvell Technology has surged in 2026 as AI infrastructure demand accelerates. Here is a timely look at the case for ...
FuelCell Energy surges on a major data-center deal, while Bloom Energy retreats, underscoring a rare divergence in th...
AMD’s surprise move to buy MEXT promises AI-driven memory optimization that could trim data center costs. Learn what ...
Investors often chase certainty, but the loudest promises can hide fragile fundamentals. This guide shows how to spot...
The market buzz around Sweetgreen stock is loud, but hype isn’t a plan. This article weighs momentum against business...
Biotech investing often rides on data, not on dreams. This educational piece uses a fictional company to show how wal...
Investors are asking why lucid stock jump this week. The answer lies in a fresh turnaround plan, improved liquidity h...
Intel's stock jump last month surprised many. This article digs into the catalysts behind here's intel stock soared a...
Bitcoin Suisse has secured regulatory clearance to offer institutional digital asset services in the UAE. The move ma...
SBI VC Trade reports a surge in corporate demand for Bitcoin and XRP as Japanese firms rebalance treasuries amid a we...